    <SEC-DOCUMENT>0001213900-25-106708-index.html : 20251105
    <SEC-HEADER>0001213900-25-106708.hdr.sgml : 20251105
    <ACCEPTANCE-DATETIME>20251105170342
    ACCESSION NUMBER:		0001213900-25-106708
    CONFORMED SUBMISSION TYPE:	ARS
    PUBLIC DOCUMENT COUNT:		1
    CONFORMED PERIOD OF REPORT:	20241231
    FILED AS OF DATE:		20251105
    DATE AS OF CHANGE:		20251105
    EFFECTIVENESS DATE:		20251105

    FILER:

    	COMPANY DATA:
    		COMPANY CONFORMED NAME:			Actinium Pharmaceuticals, Inc.
    		CENTRAL INDEX KEY:			0001388320
    		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
    		ORGANIZATION NAME:           	03 Life Sciences
    		EIN:				880378336
    		STATE OF INCORPORATION:			DE
    		FISCAL YEAR END:			1231

    	FILING VALUES:
    		FORM TYPE:		ARS
    		SEC ACT:		1934 Act
    		SEC FILE NUMBER:	001-36374
    		FILM NUMBER:		251454985

    	BUSINESS ADDRESS:
    		STREET 1:		100 PARK AVE., 23RD FLOOR
    		CITY:			NEW YORK
    		STATE:			NY
    		ZIP:			10017
    		BUSINESS PHONE:		(646) 677-3870

    	MAIL ADDRESS:
    		STREET 1:		100 PARK AVE., 23RD FLOOR
    		CITY:			NEW YORK
    		STATE:			NY
    		ZIP:			10017

    	FORMER COMPANY:
    		FORMER CONFORMED NAME:	Cactus Ventures, Inc.
    		DATE OF NAME CHANGE:	20070130
    </SEC-HEADER>
    <DOCUMENT>
    <TYPE>ARS
    <SEQUENCE>1
    <FILENAME>ea0260530-03.pdf
    <DESCRIPTION>ARS
    <TEXT>
    Document 1 - file: ea0260530-03.pdf

    </DOCUMENT>
    </SEC-DOCUMENT>